Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00053131
What this trial is testing

Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00004145
What this trial is testing

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Testing effectiveness (Phase 2)Study completedNCT00003305
What this trial is testing

Aminopterin in Treating Patients With Refractory Leukemia

Who this might be right for
Leukemia
Genzyme, a Sanofi Company 75
Early research (Phase 1)Study completedNCT00107354
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04326439
What this trial is testing

AflacLL1901 (CHOA-AML)

Who this might be right for
Acute Myeloid LeukemiaAML, Childhood
Emory University 8
Not applicableNot Yet RecruitingNCT07115537
What this trial is testing

The Prognostic Significance of Platelet to White Blood Cell Ratio (PWR) in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assiut University 60
Early research (Phase 1)Study completedNCT00003005
What this trial is testing

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Boston Medical Center 14
Early research (Phase 1)Ended earlyNCT03203369
What this trial is testing

Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Cellectis S.A. 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03609060
What this trial is testing

Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 120
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00027820
What this trial is testing

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Testing effectiveness (Phase 2)Study completedNCT02182596
What this trial is testing

DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 20
Not applicableLooking for participantsNCT07627568
What this trial is testing

Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.

Who this might be right for
Acute Myeloid Leukemia
University of Freiburg 20
Testing effectiveness (Phase 2)Study completedNCT01063660
What this trial is testing

Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
medac GmbH 75
Early research (Phase 1)Study completedNCT03459859
What this trial is testing

Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS

Who this might be right for
Acute Myelogenous LeukemiaAMLAdvanced Myelodysplastic Syndromes+1 more
Justin Watts, MD 12
Large-scale testing (Phase 3)Ended earlyNCT03765541
What this trial is testing

Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
University Hospital, Toulouse 73
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00017589
What this trial is testing

Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Genta Incorporated
Next Page